Dallas, TX (PRWEB) September 14, 2012
The Yaz Resource Center, a patient advocacy group, is alerting women who suffered blood clots after taking the birth control medications Yaz or Yasmin that the drug maker, Bayer, has begun settling claims. However, victims are advised that only certain cases may qualify and a claim must be submitted with an experienced lawyer.
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Yaz Resource Center or speak with a lawyer about their legal rights.
On October 25, 2011, the British Medical Journal published a study from the University of Copenhagen which linked the hormone in Yaz to blood clots. The FDA followed on October 27, 2011 with its own study entitled "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints" which found drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.
On May 31, 2012, the QuarterWatch report from the Institute for Safe Medicine Practices ranked Yaz and Yasmin second highest in 2011 for the number of complications reported to the FDA.
Due to the number of patients that have filed a Yaz lawsuit, a federal Multi-District Litigation court was established in Illinois to handle the claims. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois). The court estimates that more than 10,000 patients have filed a claim.
According to Bloomberg News on July 31st, Bayer has started settling Yaz lawsuits, with as many as 1900 resolved so far. They have also reserved up to $610 million to dispense the cases at an average of around $212,000.
With settlement news spreading, the Yaz Resource Center has received inquiries from patients who’ve been promised quick settlements and lawsuit proceeds within days. While a Yaz lawsuit is possible, a lawyer must present medical records and documents, which can take months. Anyone who is told otherwise should be suspicious.
Patients who settle a Yaz lawsuit may be offered an advancement or loan on their case, however, this should be avoided if possible as these types of loans often charge high interest rates of 20% or more.
The Yaz Resource Center cautions that victims should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.
For more information on research, side effects and litigation news related to the drug Yaz, or to speak with a lawyer, visit http://www.YazLawsuit.com.